INTERNATIONAL PATENT: ADARX PHARMACEUTICALS, INC. FILES APPLICATION FOR "MAPT-MODULATING OLIGONUCLEOTIDES FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES"

GENEVA, May 6 -- ADARX PHARMACEUTICALS, INC. (ADARx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego, CA 92121) filed a patent application (PCT/US2025/052172) for "MAPT-MODULATING OLIGONUCLEOTIDES FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES" on Oct 23, 2025. With publication no. WO/2026/090357, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Zhen (c/o ADARx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego, CA 92121), ZHU, Rui (c/o ADARx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego...